Pan-European Research Network
SEREN
Connecting Europe's space life sciences researchers across disciplines, borders, and missions
Space Life Sciences European Research Network
Explore
Pan-European Research Network
Connecting Europe's space life sciences researchers across disciplines, borders, and missions
Europe's expertise in space life sciences remains fragmented. SEREN exists to change that.
SEREN is a pan-European interdisciplinary network in space life sciences. Across national systems and disciplinary silos, exceptional work in space biology, biotechnology, and biomedical research goes unconnected — limiting Europe's collective impact.
SEREN addresses this gap by connecting researchers, industry partners, policymakers, and civil society in a coherent, mission-driven network. The network is grounded in a dual-use innovation model: leveraging space environments as unique experimental platforms while translating findings into terrestrial solutions for ageing, health resilience, food security, and sustainability.
With 70+ researchers from 20+ institutions across Europe, SEREN advances Horizon Europe's mission-oriented research goals and ESA's Terrae Novae exploration priorities — positioning Europe competitively within a global space economy projected to exceed $1.8 trillion by 2035.
Astronaut data and microgravity biology translated into new therapies and biotech products. Bridging space physiology with terrestrial advances in ageing, metabolic health, and disease resilience.
Space mission constraints as drivers of circular economy and resource efficiency technologies. From closed-loop life support systems to sustainable terrestrial applications, scarcity becomes innovation.
Integrating Europe's space and biotech sectors to accelerate breakthroughs and skills retention. Structured pathways to Horizon Europe consortia, ESA-industry partnerships, and COST Innovators Grants.
Six interdisciplinary working groups spanning the full research-to-application pipeline — from astronaut physiology to public outreach.
Physiological and metabolic responses to space environments — ageing, mitochondrial function, cognitive changes, long-term health risks.
Microbial ecosystems in closed habitats, immune regulation, gut-brain-microbiome interactions, synthetic biology, biomining, and therapeutic peptide production.
Biosystems for closed-loop sustainability — plant growth, oxygen production, waste recycling, and water filtration for space habitats.
Organoids, organ-on-chip models, 3D bioprinting, stem cell therapy, and tissue engineering for long-duration missions and low-resource environments.
Drug discovery, stability, personalised medicine, miniaturised diagnostics, remote health monitoring, telemedicine, and pharmacovigilance for space and Earth.
Internal and external communication, public outreach, stakeholder relations, ethical framing of research, science diplomacy, and SEREN's visual and strategic identity.
| Country | Organisation | Contact |
|---|---|---|
| Armenia | DEPI Space Research Hub | Ms Gayane Hakobyan |
| Belgium | Space Applications Services NV | Dr Miguel Ferreira |
| Bulgaria | Roumen Tsanev Institute of Molecular Biology, BAS / EPIX.AI | Prof Milena Georgieva |
| France | MEDES – Institut de Médecine et Physiologie Spatiale (IMPS) | Dr Adeline Martin |
| France | ALATYR | Mr Alexandre Becache |
| Lithuania | Delta Biosciences | Mr Dominykas Milasius |
| Malta | SPACEOMIX | Dr Joseph Borg |
| Poland | Extremo Technologies | Ms Wiktoria Dziadula / Ms Ewa Borowska |
| United Kingdom | Apotech in Extreme | Dr Li Shean Toh |
Advances Horizon Europe mission-oriented research and ESA's Terrae Novae exploration priorities.
Supports the emerging EU Space Act and EU Biotech Act policy frameworks.
Creates structured pathways to Horizon Europe consortia and ESA-industry partnerships.
Positions Europe competitively within a global space economy projected to exceed $1.8 trillion by 2035.